Psychiatry and
Behavioral Sciences–

Charles DeBattista

Back to Profile

Publication Details

  • An open label trial of C-1073 (mifepristone) for psychotic major depression.

    Belanoff JK, Rothschild AJ, Cassidy F, DeBattista C, Baulieu EE, Schold C, Schatzberg AF. Biol Psychiatry. 2002; 52 (5): 386-92

    The rationale for treating patients with psychotic major depression (PMD) with glucocorticosteroid receptor (GR) antagonists is explained.

    PubMedID: 12242054

Stanford Medicine Resources:

Footer Links: